|
Other links at Biotechnology and Pharmaceuticals > Pharmaceuticals > Research and Development |
| 1. |
EXIMIAS Pharmaceutical Corporation
|
|
|
Specialty pharmaceutical company focusing on acquisition, development, and commercialization of oncology and infectious disease products. Three late-stage products: THYMITAQ, ORATAQ and MACROTAC.
|
| 2. |
Pharmaceutica Limited
|
|
|
Site contains overview of new anti-infective technology developed by the company and problems of drug resistance in general. Bacterial Transforming Agents change antibiotic-resistant bacteria, e.g. MRSA, into antibiotic-susceptible bacteria.
|
| 3. |
Mpex Pharmaceuticals, Inc.
|
|
|
Specializes in combining inhibitors of bacterial resistance with proven antibiotics to treat serious infections. Based in San Diego, California.
|
| 4. |
Rentschler Biotechnology
|
|
|
Your partner for contract development and production of biopharmaceuticals. The company is primarily engaged in development, clinical testing, production and analysis of proteins for human therapeutic or diagnostic use according to international standards.
|
| 5. |
Agennix
|
|
|
A player in the development of recombinant human lactoferrin (rhLF), is a biopharmaceutical company focused on developing protein-based drugs for oncology, asthma and wound healing.
|
|
|
Add to My Favorite
Refer it to Friend
Report Broken Link
